Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NovaTechs logo — NovaTechs: Transforming Vascularized Tumor Treatment with Li...

NovaTechs

NovaTechs: Transforming Vascularized Tumor Treatment with Liquid Precision

Founded 2020 The Netherlands The Netherlands 4 employees Biotechnology, Health Care +1

General Information

Company Name NovaTechs
Founded Year 2020
Location The Netherlands The Netherlands +1
Employees 4
Industries Biotechnology, Health Care, Medical Devices
Social

Get notified when NovaTechs moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NovaTechs

NovaTechs is a forward-thinking startup founded in 2020, specializing in innovative healthcare solutions, particularly focusing on developing a cutting-edge liquid embolic agent. This pioneering technology offers a precise, minimally invasive approach to the embolization of vascularized tumors, seeking to streamline and transform medical procedures in tumor treatment.

The company's mission centers on advancing medical intervention methods, ensuring the liquid embolic agent provides targeted occlusion of blood vessels, ultimately enhancing patient outcomes in cancer care. NovaTechs is committed to breaking new ground in tumor embolization, promising a significant impact on healthcare delivery worldwide.

While currently not partnered with investors, NovaTechs is an enticing opportunity for potential backers interested in contributing to the global advancement of medical technology, offering promising prospects in a vital sector of healthcare innovation.

Taxonomy: Liquid Embolic Agents, Vascularized Tumor Embolization, Medical Intervention, Healthcare Innovation, Tumor Treatment, Interventional Radiology, Oncology Therapeutics, Minimally Invasive Solutions, Medical Technology, Cancer Care Advancements, Medical Procedure Streamlining, Healthcare Professional Support, Precision Medicine

Services & Products

Hydrogel Product Development
Embolization Procedures
Interventional Radiology Solutions

Target Customers

Medical Professionals Radiologists Hospitals Healthcare Institutions

No funding data available for NovaTechs yet.

Get notified when NovaTechs raises funding

NovaTechs Alternatives & Competitors

NovaTechs vs
NSV Inc
NSV Inc United States

Reshaping Healthcare and Improving Patient Outcomes through Innovation

91 employees
AI, Health Care
NovaTechs vs
PuzzleAI
PuzzleAI Korea South

Transforming Healthcare with AI Innovation – Join Puzzle AI to Shape the Future of Medicine and Arti...

Private Equity
11 employees
AI
NovaTechs vs
SilverStream Medical
SilverStream Medical Israel

Innovative Solutions For Wounds And Burns Treatment

7 employees
Health Care, Life Sciences

FAQ About NovaTechs

NovaTechs: Transforming Vascularized Tumor Treatment with Liquid Precision
NovaTechs was founded in 2020.
NovaTechs is headquartered in The Netherlands.
NovaTechs operates in the following industries: Biotechnology, Health Care, Medical Devices.
NovaTechs has approximately 4 employees.
NovaTechs offers: Hydrogel Product Development, Embolization Procedures, Interventional Radiology Solutions.
Top alternatives and competitors to NovaTechs include NSV Inc, PuzzleAI, SilverStream Medical, BAYOOMED, Bottneuro AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NovaTechs and NSV Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NovaTechs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy